Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer

Matthias Eiber, Matthias Heck, Robert Tauber, Isabel Rauscher, Calogero D`Alessandria, Tobias Maurer, Margitta Retz, Hans Wester and Markus Schwaiger
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 61;
Matthias Eiber
4Techinical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Heck
4Techinical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Tauber
4Techinical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Rauscher
1Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Calogero D`Alessandria
4Techinical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Maurer
2Department of Urology Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margitta Retz
4Techinical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Wester
5Technische Universitaet Muenchen Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
3Klinikum rechts der Isar TU Muenchen Muenchen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 61

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Matthias Eiber4,
  2. Matthias Heck4,
  3. Robert Tauber4,
  4. Isabel Rauscher1,
  5. Calogero D`Alessandria4,
  6. Tobias Maurer2,
  7. Margitta Retz4,
  8. Hans Wester5 and
  9. Markus Schwaiger3
  1. 1Munich Germany
  2. 2Department of Urology Munich Germany
  3. 3Klinikum rechts der Isar TU Muenchen Muenchen Germany
  4. 4Techinical University Munich Munich Germany
  5. 5Technische Universitaet Muenchen Garching Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016500
Jun 20165700
Jul 20164000
Aug 20163500
Sep 20161500
Oct 20162500
Nov 20162800
Dec 20161400
Jan 20173000
Feb 20172600
Mar 20171400
Apr 20171300
May 2017700
Jun 2017500
Jul 2017800
Aug 2017500
Sep 2017200
Oct 2017800
Nov 2017500
Dec 2017100
Jan 2018800
Feb 2018600
Mar 2018500
Apr 2018800
May 2018500
Jun 2018700
Jul 2018600
Aug 2018600
Sep 2018100
Oct 2018700
Nov 2018200
Dec 2018600
Jan 20192500
Feb 2019900
Mar 2019500
Apr 20191100
May 2019200
Jun 20191300
Jul 20192300
Aug 2019300
Sep 20191300
Oct 2019300
Nov 2019300
Dec 2019200
Jan 2020200
Feb 20201000
Mar 20201500
Apr 20201200
May 20202100
Jun 20201900
Jul 20201400
Aug 20201600
Sep 20203200
Oct 20202700
Nov 20202500
Dec 20201300
Jan 2021800
Feb 20211700
Mar 20211000
Apr 20214500
May 20213000
Jun 20211700
Jul 20212200
Aug 20214300
Sep 20212100
Oct 20211800
Nov 20218800
Dec 20216000
Jan 202210100
Feb 20222100
Mar 20224900
Apr 20223400
May 20226400
Jun 20224800
Jul 20221300
Aug 20222300
Sep 20221300
Oct 20221800
Nov 2022800
Dec 2022300
Jan 2023400
Feb 20231000
Mar 2023200
Apr 2023900
May 2023400
Jun 2023800
Jul 2023400
Aug 20231200
Sep 2023700
Oct 2023500
Nov 2023500
Dec 2023600
Jan 2024400
Feb 2024300
Mar 2024400
Apr 2024400
May 20241000
Jun 2024600
Jul 2024300
Aug 2024900
Sep 2024700
Oct 2024600
Nov 20241300
Dec 2024700
Jan 2025400
Feb 20251300
Mar 2025700
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
Matthias Eiber, Matthias Heck, Robert Tauber, Isabel Rauscher, Calogero D`Alessandria, Tobias Maurer, Margitta Retz, Hans Wester, Markus Schwaiger
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 61;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
Matthias Eiber, Matthias Heck, Robert Tauber, Isabel Rauscher, Calogero D`Alessandria, Tobias Maurer, Margitta Retz, Hans Wester, Markus Schwaiger
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 61;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

CMIIT Young Investigator Award

  • Self-assembled NIR-II dye conjugated small peptides for bone imaging
  • Visualization of activated macrophages using a translocator protein ligand, 18F-FEDAC, in a rheumatoid arthritis model
  • Image-guided cancer surgery using a novel nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging
Show more CMIIT Young Investigator Award

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire